The business in question is a profitable and stable enterprise operating in the health category with a net monthly recurring revenue (MRR) of $60,000, post-decline. It retains about 60% of its subscribers over six months, demonstrating a strong, predictable revenue stream. Year-to-date (YTD) profit in 2026 is $90,000, running consistently at approximately $20,000 monthly after recovering from a one-time $30,000 product launch investment. The company offers growth potential, having largely unmarketed its second product and possessing a library of undeployed creative assets. Current acquisition efforts are driven by social media platforms with a sustainable blended return on ad spend (ROAS) of 2.15. The customer base is primarily women aged 35-65 in the U.S., who are aware of and seeking solutions for urinary health. Financially, the company registered a trailing 12-month revenue of $500,000, with a monthly profit run rate of around $20,000. Operating costs are manageable and could be absorbed by an acquirer with internal capabilities. The business model, based on refined marketing strategies, shows no seasonality with steady year-round revenue. It is designed for stable cash flow, with real growth opportunities remaining untapped. The owner plans to exit to allocate resources to a new venture, though the brand remains in strong operational health. Transition support is offered post-sale, including supplier introductions and strategy guidance. This sale is strategic rather than forced, allowing the acquirer to leverage existing business assets for further growth.